Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical relevance of mosaic variants detected by exome sequencing.

The Journal of allergy and clinical immunology·2026
Same author

Evidence for dysbiosis in the gut microbiome of patients with systemic mastocytosis.

The journal of allergy and clinical immunology. Global·2026
Same author

Evolution of mast cell research associated with the Laboratory of Allergic Diseases, 1985-2022: Summary of the 2023 NIAID Symposium.

The Journal of allergy and clinical immunology·2025
Same author

Prevalence of myeloid gene alterations in paediatric cutaneous and systemic mastocytosis.

British journal of haematology·2025
Same author

Treatment of indolent systemic mastocytosis with sarilumab is not supported in a randomized trial.

The journal of allergy and clinical immunology. Global·2025
Same author

Fire ant-venom anaphylaxis prevalence in the general population and patients with systemic mastocytosis.

Frontiers in allergy·2025
Same journal

Educational programmes in food allergy.

Chemical immunology and allergy·2015
Same journal

Prevention of food allergy.

Chemical immunology and allergy·2015
Same journal

The effects of food allergy on quality of life.

Chemical immunology and allergy·2015
Same journal

Worldwide food allergy labeling and detection of allergens in processed foods.

Chemical immunology and allergy·2015
Same journal

Food allergy: psychosocial impact and public policy implications.

Chemical immunology and allergy·2015
Same journal

Nutritional aspects and diets in food allergy.

Chemical immunology and allergy·2015
See all related articles

Related Experiment Video

Updated: Jun 12, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Mastocytosis.

Knut Brockow, Dean D Metcalfe

    Chemical Immunology and Allergy
    |June 4, 2010
    PubMed
    Summary
    This summary is machine-generated.

    Patients with mast cell disorders, including mastocytosis and monoclonal mast cell activation syndrome (MMAS), face a higher risk of anaphylaxis. Early recognition of these conditions is crucial for patient safety.

    More Related Videos

    Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
    09:07

    Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

    Published on: May 27, 2015

    Related Experiment Videos

    Last Updated: Jun 12, 2026

    Spontaneous Murine Model of Anaplastic Thyroid Cancer
    05:39

    Spontaneous Murine Model of Anaplastic Thyroid Cancer

    Published on: February 3, 2023

    Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
    09:07

    Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice

    Published on: May 27, 2015

    Area of Science:

    • Immunology
    • Hematology
    • Allergy and Immunology

    Background:

    • Mastocytosis is associated with an increased risk of anaphylaxis.
    • Monoclonal mast cell activation syndrome (MMAS) also presents an elevated anaphylaxis risk, even without a full mastocytosis phenotype.
    • Recognition of mast cell disorders is key, as they are often linked to recurrent anaphylaxis.

    Purpose of the Study:

    • To describe the features of mast cell clonality, MMAS, and mastocytosis.
    • To review recent findings related to these mast cell disorders.
    • To emphasize the importance of considering mast cell disorders in patients experiencing recurrent anaphylaxis.

    Main Methods:

    • Review of clinical features and diagnostic markers for mast cell disorders.
    • Analysis of indicators such as skin lesions, serum tryptase levels, and mast cell immunophenotyping (CD25, CD2).
    • Examination of histopathological findings including mast cell clustering, morphology, and KIT proto-oncogene mutations.

    Main Results:

    • Mastocytosis and MMAS increase the risk of anaphylaxis.
    • Characteristic skin lesions and elevated baseline serum mast cell tryptase are indicators of clonal mast cell disorders.
    • Abnormal CD25/CD2 immunostaining, mast cell clustering, abnormal morphology, and c-kit mutations are markers for mast cell clonality.

    Conclusions:

    • Mast cell clonality, MMAS, and mastocytosis are significant risk factors for anaphylaxis.
    • Understanding these conditions is essential for accurate diagnosis and management.
    • Mast cell disorders should be considered in the differential diagnosis of patients with recurrent anaphylaxis.